Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011): A Phase 3, Randomized, Double-Blind Trial von Matsubara, Nobuaki, de Wit, Ronald, Balar, Arjun Vasant, Siefker-Radtke, Arlene O., Zolnierek, Jakub, Csoszi, Tibor, Shin, Sang Joon, Park, Se Hoon, Atduev, Vagif, Gumus, Mahmut, Su, Yu-Li, Karaca, Saziye Burcak, Cutuli, Hernán Javier, Sendur, Mehmet A.N., Shen, Liji, O'Hara, Karen, Okpara, Chinyere E., Franco, Sonia, Moreno, Blanca Homet, Grivas, Petros, Loriot, Yohann

Volltext

Access of patients with breast and lung cancer to chemotherapy treatment in public and private hospitals in the city of Buenos Aires von Recondo, Gonzalo, Cosacow, César, Cutuli, Hernán Javier, Cermignani, Luciano, Straminsky, Samanta, Naveira, Martin, Pitzzu, Martin, De Ronato, Gabriela, Nacuzzi, Gabriela, Taetti, Gonzalo, Corsico, Santiago, Berrueta, Mabel, Colucci, Giuliana, Gibbons, Luz, Gutierrez, Laura, García-Elorrio, Ezequiel

Volltext

Transformation of teratoma in rabdomiosarcoma von Cutuli, Hernán J, Barciocco, Carolina, Rojas Bilbao, Érica, Brzezinski, Mariano, Gandur Quiroga, María Natalia, Pasik, Leonardo

Volltext

Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer von Catto, J W F, Tran, B, Rouprêt, M, Gschwend, J E, Loriot, Y, Nishiyama, H, Redorta, J P, Daneshmand, S, Hussain, S A, Cutuli, H J, Procopio, G, Guadalupi, V, Vasdev, N, Naini, V, Crow, L, Triantos, S, Baig, M, Steinberg, G

Volltext

PIVOT IO 009: A phase 3, randomized study of neoadjuvant and adjuvant nivolumab (NIVO) plus bempegaldesleukin (BEMPEG; NKTR-214) versus NIVO alone versus standard of care (SOC) in... von Grivas, Petros, Van Der Heijden, Michiel Simon, Necchi, Andrea, Siefker-Radtke, Arlene O., Cutuli, Hernan, Qureshi, Anila H., Kreiser, Stephanie, Hodari, Moana, Ravimohan, Shruthi, Zakharia, Yousef

Volltext

Subcutaneous nivolumab versus intravenous nivolumab in patients with previously treated, advanced, or metastatic clear cell renal cell carcinoma von Chacon, Matias Rodrigo, Cutuli, Hernan J., Bracarda, Sergio, Maruzzo, Marco, Bourlon, Maria Teresa, Jacobs, Carmel, Pérez-Valderrama, Begoña, Magri, Ignacio, Richardet, Martin, Centkowski, Piotr, Fu, Simon Yuen Fai, Gurman, Pablo, Konduri, Srivani, Yu, Zhuoxin, Vezina, Heather, George, Saby, Albiges, Laurence

Volltext

MARKER LESION STUDY OF ORAL ERDAFITINIB IN PATIENTS WITH INTERMEDIATE-RISK NON-MUSCLE–INVASIVE BLADDER CANCER WITH FGFR3/2 ALTERATIONS IN THOR-2: UPDATED COHORT 3 RESULTS von Daneshmand, Siamak, Zaucha, Renata, Vasdev, Nikhil, Gartrell, Benjamin A, Lotan, Yair, Hussain, Syed A, Lee, Eugene K, Procopio, Giuseppe, Galanternik, Fernando, Pignot, Geraldine, Sundi, Debasish, Cutuli, Hernan J, Crow, Lauren, Naini, Vahid, Triantos, Spyros, Baig, Mahadi, Maranchie, Jodi K

Volltext

First-line pembrolizumab (pembro) with or without lenvatinib (lenva) in patients with advanced urothelial carcinoma (LEAP-011): A phase 3, randomized, double-blind study von Loriot, Yohann, Grivas, Petros, De Wit, Ronald, Balar, Arjun Vasant, Siefker-Radtke, Arlene O., Zolnierek, Jakub, Csoszi, Tibor, Shin, Sang Joon, Park, Se Hoon, Atduev, Vagif, Gumus, Mahmut, Su, Yu-Li, Karaca, Saziye Burcak, Cutuli, Hernan, Sendur, Mehmet Nahit, Jia, Calvin, O'Hara, Karen, Franco, Sonia, Matsubara, Nobuaki

Volltext

First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study von El Zarif, Talal, Semaan, Karl, Xie, Wanling, Eid, Marc, Zarba, Martin, Issa, Wadih, Zhang, Tian, Nguyen, Charles B., Alva, Ajjai, Fahey, Catherine C., Beckermann, Kathryn E., Karam, Jose A., Campbell, Matthew T., Procopio, Giuseppe, Stellato, Marco, Buti, Sebastiano, Zemankova, Anezka, Melichar, Bohuslav, Massari, Francesco, Mollica, Veronica, Venugopal, Balaji, Ebrahimi, Hedyeh, de Velasco, Guillermo, Gurney, Howard Paul, De Giorgi, Ugo, Parikh, Omi, Winquist, Eric, Master, Viraj, Garcia, Abraham Ruiz, Cutuli, Hernan Javier, Ferguson, Thomas Robert, Gross-Goupil, Marine, Baca, Sylvan C., Pal, Sumanta K., Braun, David A., McKay, Rana R., Heng, Daniel Y.C., Choueiri, Toni K.

Volltext

UPDATED EFFICACY AND SAFETY OF ORAL ERDAFITINIB IN PATIENTS WITH BACILLUS CALMETTE-GUÉRIN–UNRESPONSIVE, HIGH-RISK NON-MUSCLE–INVASIVE BLADDER CANCER WITH FGFR3/2 ALTERATIONS IN THO... von Catto, James WF, Hussain, Syed A, Tran, Ben, Pignot, Geraldine, Master, Viraj, Rouprêt, Morgan, Tubaro, Andrea, Shimizu, Nobuaki, Vasdev, Nikhil, Nishiyama, Hiroyuki, Daneshmand, Siamak, Miura, Yuji, Chlosta, Piotr L, Cutuli, Hernan J, Luz, Murilo Almeida, Crow, Lauren, Naini, Vahid, Triantos, Spyros, Baig, Mahadi, Steinberg, Gary

Volltext

Access to oncological care in patients with breast and lung cancer treated at public and private hospitals in Buenos Aires, Argentina von Recondo, Gonzalo, Cosacow, Cesar, Cutuli, Hernan J, Cermignani, Luciano, Straminsky, Samanta, Naveira, Alejandro M, Pitzzu, Martin, De Ronato, Gabriela Antares, Nacuzzi, Gabriela, Taetti, Gonzalo, Corsico, Santiago, Colucci, Giuliana, Berrueta, Mabel, Garcia Elorrio, Ezequiel

Volltext

The Impact of Fibroblast Growth Factor Receptor Alterations in Clinical Outcomes of Patients With Advanced Urothelial Carcinoma: Real-World Data From a Latin American Population von Souza, Vinicius Carrera, Monteiro, Fernando Sabino Marques, Maluf, Fernando Cotait, Werutsky, Gustavo, Fabrício, Vanessa de Carvalho, Gidekel, Rosemarie, Gandur-Quiroga, Maria Natalia, Freitas, Marcelo Roberto Pereira, Luz, Murilo, Campos-Gomez, Saul, Junior, Jose Augusto Rinck, Bastos, Diogo Assed, Sade, Juan Pablo, da Trindade, Karine Martins, Mota, Augusto Cesar de Andrade, Fernandes, Roni de Carvalho, Ruíz, Allan Omar Barillas, Pereira e Silva, Breno Dauster, de Oliveira, Fernando Nunes Galvão, Cutuli, Hernan Javier, Nogueira, Lucas, Aceituno, Luis Fernando García, Fernandez, Mauricio, Inman, Eva, Caitano, Manuel, Herchenhorn, Daniel, Ardila-Salcedo, Jaime, Pacheco, Patrícia, de Jesus, Rafaela Gomes, Gössling, Gustavo, Soares, Andrey, Fay, André Poisl

Volltext

Adjuvant nivolumab plus ipilimumab vs placebo for patients with localized renal cell carcinoma at high risk of relapse after nephrectomy: Subgroup analyses from the phase 3 CheckMa... von Motzer, Robert J., Russo, Paul, Grünwald, Viktor, Tomita, Yoshihiko, Barthélémy, Philippe, Goh, Jeffrey C., Cutuli, Hernán Javier, Simsek, Burcin, Spiridigliozzi, Julia, Chudnovsky, Aleksander, Bex, Axel

Volltext

Which biological pathways are responsible for the late appearance of brain metastases in renal cell carcinoma? Analysis of eight cases von Minghinelli, Federico E., Recalde, Rodolfo José, Prost, Diego Martín, Cutuli, Hernán Javier, Giovannini, Sebastián Juan María, Zaninovich, Roberto Steven

Volltext

Transformation of teratoma in rabdomiosarcoma von Cutuli, Hernán J, Barciocco, Carolina, Rojas Bilbao, Érica, Brzezinski, Mariano, Gandur Quiroga, María Natalia, Pasik, Leonardo

Volltext